This is VAERS ID 903016

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/18/2020

Vaccin­ation / Manu­facturer (1 vaccine)	Lot / Dose	Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH	EK5730 / 1	LA / IM

Administered by: Private      Purchased by: ??
Symptoms: Anaphylactic reaction, Chest X-ray, Dyspnoea, Flushing, Hypoaesthesia, Panic attack, Paraesthesia, Respiratory rate increased, Tremor, Laboratory test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: migraine, obstructive sleep apnea
Allergies: clindamycin, clotrimazole, dihydroergotamine, IV contrast medium, prochlorperazine, promethazine, sumatriptan
Diagnostic Lab Data:
CDC 'Split Type':

Write-up: Approximately 11 minutes after receiving the vaccine, the patient complained of shortness of breath, tingling in arms and hands, numbness and tingling in legs and feet, and was observably shaking, with no complaints of swelling in throat or other signs of anaphylaxis. Patient was brought to ER in same facility via stretcher and was examined by staff there. ER report states the patient presented with shortness of breath and what appeared to be a panic attack, with fast breathing, slight flushing, and shaking. Per ER report, the patient was treated for an acute anaphylactic reaction, with clear lungs and given an EpiPen shot in the right thigh. IV was initiated and given a fluid bolus, solu medrol, famotidine, and lorazepam. Labs and a chest x-ray done and reviewed. After treatment, patient found to be stable and was discharged home at 4:42 pm with orders for famotidine, albuterol inhaler, and epinephrine pen.

New Search